pioglitazone has been researched along with perindopril in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kampoli, AM; Miliou, A; Oikonomou, E; Pallantza, Z; Papageorgiou, N; Paterakis, G; Stefanadis, C; Tousoulis, D; Vlachopoulou, A | 1 |
1 review(s) available for pioglitazone and perindopril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for pioglitazone and perindopril
| Article | Year |
|---|---|
Comparable effects of pioglitazone and perindopril on circulating endothelial progenitor cells, inflammatory process and oxidative stress in patients with diabetes mellitus.
Topics: Aged; Diabetes Mellitus; Endothelial Cells; Female; Hematopoietic Stem Cells; Humans; Inflammation; Male; Middle Aged; Oxidative Stress; Perindopril; Pioglitazone; Thiazolidinediones | 2012 |